BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6751365)

  • 21. Augmentin (amoxicillin/clavulanate) in the treatment of community-acquired respiratory tract infection: a review of the continuing development of an innovative antimicrobial agent.
    White AR; Kaye C; Poupard J; Pypstra R; Woodnutt G; Wynne B
    J Antimicrob Chemother; 2004 Jan; 53 Suppl 1():i3-20. PubMed ID: 14726431
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of augmentin on sputum beta-lactamase activity in patients with cystic fibrosis.
    Penketh AR; Hodson ME; Batten JC
    Br J Clin Pract; 1984 May; 38(5):188-9. PubMed ID: 6610437
    [No Abstract]   [Full Text] [Related]  

  • 23. Amoxycillin-clavulanic acid combination in bronchopulmonary infection due to beta-lactamase-producing Branhamella catarrhalis. Preliminary report.
    Thornley PE; Aitken JM; Nichol GM; Slevin NJ
    Drugs; 1986; 31 Suppl 3():113-4. PubMed ID: 3525087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amoxicillin and clavulanic acid combination: clinical and laboratory evaluation in pulmonary infections.
    Saroglou G; Paniara-Volika O; Sima A; Paraskevopoulou E; Makris G; Hatzimichelakis N; Vassilopoulos N; Kontomichalou P
    Clin Ther; 1982; 4(6):442-9. PubMed ID: 6980050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Parenteral augmentin: pharmacokinetics.
    Staniforth DH; Jackson D; Horton R; Davies B
    Int J Clin Pharmacol Ther Toxicol; 1984 Aug; 22(8):430-4. PubMed ID: 6490225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of the efficacy and safety of cefuroxime axetil and augmentin in the treatment of upper respiratory tract infections.
    Hebblethwaite EM; Brown GW; Cox DM
    Drugs Exp Clin Res; 1987; 13(2):91-4. PubMed ID: 3582135
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Respiratory tract infections caused by beta-lactamase producing organisms treated with augmentin.
    Mehtar S
    Scott Med J; 1982; 27 Spec No.():S24-7. PubMed ID: 6984777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Augmentin compared with oxytetracycline for chest infections in general practice.
    Boston PF; Gowers E; Rose AJ
    Br J Dis Chest; 1986 Apr; 80(2):148-56. PubMed ID: 3524647
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Trimethoprim-sulfamethoxazole versus amoxycillin in the therapy of acute bacterial exacerbations in chronic non-specific respiratory tract diseases. A controlled study].
    Ramer P; Medici TC; Hatt RR; Unger S; Ronner B
    Schweiz Med Wochenschr; 1981 Nov; 111(48):1823-9. PubMed ID: 7034198
    [No Abstract]   [Full Text] [Related]  

  • 30. A clinical and bacteriological evaluation of Augmentin: a new broad spectrum antibiotic in general practice.
    Hansrod D; Howalder R; Rozar GJ
    East Afr Med J; 1983 Nov; 60(11):778-82. PubMed ID: 6368188
    [No Abstract]   [Full Text] [Related]  

  • 31. Augmentin (amoxycillin and clavulanic acid) in the treatment of urinary tract infections.
    Leigh A
    Scott Med J; 1982; 27 Spec No.():S28-34. PubMed ID: 6984778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of beta-lactamases in the response of pulmonary infections to amoxycillin/clavulanate.
    Stockley RA; Dragicevic P; Burnett D; Hill SL
    J Antimicrob Chemother; 1989 Nov; 24 Suppl B():73-81. PubMed ID: 2606821
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Roxithromycin vs amoxycillin/clavulanic acid in lower respiratory tract infections.
    Brett W
    N Z Med J; 1994 Aug; 107(983):319-20. PubMed ID: 8052477
    [No Abstract]   [Full Text] [Related]  

  • 34. Extended release amoxicillin/clavulanate: optimizing a product for respiratory infections based on pharmacodynamic principles.
    Jacobs MR
    Expert Rev Anti Infect Ther; 2005 Jun; 3(3):353-60. PubMed ID: 15954852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ofloxacin versus amoxicillin in the treatment of lower respiratory tract infections. A multicenter prospective clinical trial.
    Chuard C; Regamey C
    J Chemother; 1989 Jul; 1(4 Suppl):784-5. PubMed ID: 16312638
    [No Abstract]   [Full Text] [Related]  

  • 36. An initial assessment of augmentin for the treatment of paediatric infections in general practice.
    Jeffries MG; Rose AJ; Williams HN
    Br J Clin Pract; 1983 Feb; 37(2):61-6. PubMed ID: 6860540
    [No Abstract]   [Full Text] [Related]  

  • 37. Efficacy and tolerability of an amoxycillin/clavulanic acid combination in the treatment of common bacterial infections. A general practitioner trial.
    Levenstein JH
    S Afr Med J; 1982 Jul; 62(5 Spec No):16A-20A. PubMed ID: 7046104
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is roxithromycin better than amoxicillin in the treatment of acute lower respiratory tract infections in primary care? A double-blind randomized controlled trial.
    Hopstaken RM; Nelemans P; Stobberingh EE; Muris JW; Rinkens PE; Dinant GJ
    J Fam Pract; 2002 Apr; 51(4):329-36. PubMed ID: 11978255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical effectiveness of a combination of bromhexine and amoxicillin in lower respiratory tract infection. A randomized controlled trial.
    Roa CC; Dantes RB
    Arzneimittelforschung; 1995 Mar; 45(3):267-72. PubMed ID: 7741782
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Augmentin (intravenous then oral) compared with cefuroxime followed by cephalexin for chest infections in hospitalised patients.
    O'Donovan C; Rudd R; O'Neill S; Fitzgerald MX; McNicholas W; Flavell-Matts SG; Howell F; McKenzie A; Whittaker J
    Br J Clin Pract; 1987 Dec; 41(12):1044-52. PubMed ID: 3332842
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.